CRBU
Caribou Biosciences
$1.59
+$0.02 (+1.27%)Jul 27, 2026
Key metrics
The numbers that frame CRBU today
- Market cap
- $157.70M
- P/E (TTM)
- -1.2
- EV / FCF
- -1.7
- Gross margin
- 100%
- EV / Sales
- 19.6
- ROIC
- -78.3%
- Div yield
- 0%
- Debt / equity
- 0.3
- 52wk Low
- $1.38
- 52wk High
- $3.54
Growth
Revenue and earnings trend for CRBU
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CRBU
Is Caribou Biosciences a good buy?
No. Caribou Biosciences has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks strong, which supports the long-term business case, but that is not enough to offset the weak setup. We think Caribou Biosciences is selling at a very high price.
What is the market capitalization of CRBU?
Caribou Biosciences's market capitalization is $157.70M.
What is the P/E ratio for CRBU stock?
Caribou Biosciences's current P/E ratio is -1.2.
What is the 52-week high for CRBU stock?
The 52-week high for Caribou Biosciences is $3.54. The current close of $1.59 is 55% below that high.
What is the 52-week low for CRBU stock?
The 52-week low for Caribou Biosciences is $1.38. The current close of $1.59 is 15.2% above that low.
Does CRBU stock pay dividends?
Caribou Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CRBU?
Caribou Biosciences's Debt / Equity ratio is 0.26.